During the past decade, Bakersfield Dermatology and Skin Cancer Medical Group conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 12 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bakersfield Dermatology and Skin Cancer Medical Group" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Amgen" with 4 trials sponsored, "Pfizer" with 2 trials sponsored, "Janssen Scientific Affairs, LLC" with 1 trials sponsored and "Jeffrey J Crowley MD" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bakersfield Dermatology and Skin Cancer Medical Group" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Database Integrations, Inc." with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Instat Consulting, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bakersfield Dermatology and Skin Cancer Medical Group" are "Psoriasis" (7 trials), "Atopic Dermatitis" (3 trials), "Plaque Psoriasis" (2 trials), "Psoriatic Arthritis" (2 trials) and "Dermatitis, Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Bakersfield Dermatology and Skin Cancer Medical Group" in a lesser frequency.

Most popular intervention types in "Bakersfield Dermatology and Skin Cancer Medical Group" are "Drug" (11 trials), "Biological" (4 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apremilast" (3 trials), "Lebrikizumab" (3 trials), "CP-690,550" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bakersfield Dermatology and Skin Cancer Medical Group" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Bakersfield Dermatology and Skin Cancer Medical Group". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Bakersfield Dermatology and Skin Cancer Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bakersfield Dermatology and Skin Cancer Medical Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".